Detalhe da pesquisa
1.
Variability in endometrial carcinoma pathology practice: opportunities for improvement with molecular classification.
Mod Pathol
; 35(12): 1974-1982, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36241860
2.
Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases.
Gynecol Oncol
; 165(2): 376-384, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35504673
3.
Death receptor-3, a new E-Selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation.
Cancer Res
; 66(18): 9117-24, 2006 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-16982754
4.
Proposed novel nomenclature of vulvar smooth muscle tumors; a case of Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP) of the vulva.
Gynecol Oncol Rep
; 20: 1-3, 2017 May.
Artigo
Inglês
| MEDLINE | ID: mdl-28180147
5.
Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells.
Cell Cycle
; 16(7): 693-706, 2017 Apr 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28278050
6.
Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFß1-independent manner.
Oncotarget
; 8(47): 82506-82530, 2017 Oct 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29137281
7.
Recent advances in stress signaling in cancer.
Cancer Res
; 64(5): 1893-8, 2004 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-14996754
8.
The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells.
Oncotarget
; 7(12): 14125-42, 2016 Mar 22.
Artigo
Inglês
| MEDLINE | ID: mdl-26871602
9.
Role of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.
Oncotarget
; 5(2): 544-60, 2014 Jan 30.
Artigo
Inglês
| MEDLINE | ID: mdl-24504219
10.
The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion.
Cell Cycle
; 12(6): 972-86, 2013 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-23442798
11.
Inhibition of RUNX2 transcriptional activity blocks the proliferation, migration and invasion of epithelial ovarian carcinoma cells.
PLoS One
; 8(10): e74384, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-24124450